Actively Recruiting
Using Circulating Tumor DNA to Monitor Early Treatment Response in Solid Tumor Cancers
Led by Washington University School of Medicine · Updated on 2026-02-20
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of circulating tumor DNA ctDNA to detect early treatment responses and disease recurrence in patients with various solid tumors and healthy volunteers. The study aims to enhance cancer diagnosis, treatment, surveillance, and prognosis by integrating ctDNA into clinical practice, potentially guiding personalized medical decisions. This translational research could lead to future interventional trials focusing on early therapeutic escalation using ctDNA molecular residual disease detection. Participants include healthy donors and patients with cancers such as prostate, head and neck, esophageal, genitourinary, sarcoma, breast, colon, gastrointestinal, lung, skin, and melanoma. The study involves collecting blood and urine samples as often as every two months, up to 24 times, to generate reference data and compare patient data for molecular residual disease. Samples are also obtained from various tissue and plasma repositories and banking studies related to these cancers. During the study, participants will provide biological samples for analysis, which will be used to monitor outcomes including freedom from progression, event-free survival, disease-specific survival, overall survival, pathologic complete response rate, locoregional failure, and distant-metastasis-free survival. The study is expected to continue for approximately 6.5 years, with ongoing sample collection and outcome assessment under the oversight of Washington University School of Medicine.
CONDITIONS
Brief Title
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Research Team
M
Melissa Reimers, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here